Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE2